This is the first publication that associates the promoter polymorphisms of the NOS3 gene with prostate cancer risk; however, other polymorphisms, such as the 894G>T (Glu298Asp) and the intron 4 have also been evaluated [21-24]. This evidence concerns the gene NOS3 and Familial prostate cancer.